Missed Opportunities for Human Papillomavirus Vaccination Before Sexual Debut Among Adolescents
Menée aux Etats-Unis par questionnaire auprès de 90 000 adolescents sur la période 2023-2025, cette étude identifie des facteurs démographiques et cliniques associés à l’absence de vaccination contre le papillomavirus humain avant le début de l’activité sexuelle
Human papillomavirus (HPV) vaccination is safe, effective, and provides long-lasting protection against cancers caused by HPV. Vaccination before sexual debut maximizes effectiveness, yet rates of timely vaccination remain unknown. Prior studies lack adolescent-reported sexual activity data. Using confidential adolescent surveys linked to vaccination records in a large pediatric network, we examined demographic, clinician, and practice-level factors associated with not receiving HPV vaccination before sexual debut.
JAMA Pediatrics , résumé, 2026